Ключевые слова:
дилатационная кардиомиопатия, дети, генетика, генетическое тестирование, TTN, LMNA, FLNC, генотип-фенотип, аритмия, сердечная недостаточность.Библиографические ссылки
1. 2023 ESC Guidelines for the management of cardiomyopathies. European Society of Cardiology. Eur Heart J. 2023.
2. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003; 348: 1647–1655.
3. Dai Y, Wang Y, Fan Y, Han B. Genotype-phenotype insights of pediatric dilated cardiomyopathy. Front Pediatr. 2025; 13:1505830. doi:10.3389/fped. 2025.1505830.
4. Pinto YM, Elliott PM, Arbustini E, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice. Eur Heart J. 2016; 37:1850–1858.
5. Genotype and Cardiac Outcomes in Pediatric Dilated Cardiomyopathy. J Am Coll Cardiol. 2022. PMID:34935411.
6. Clinical care of family members of patients with dilated cardiomyopathy: clinical consensus statement of the HFA/ESC. Eur Heart J. 2025; 46:4569–4582. doi:10.1093/eurheartj/ehaf571.
7. Jordan E, Peterson L, Ai X, et al. Evidence-Based Assessment of Genes in Dilated Cardiomyopathy. Circulation. 2021. PMID:33947203.
8. Herman DS, Lam L, Taylor MRG, et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012; 366:619–628.
9. Jansweijer JA, Nieuwhof K, Russo F, et al. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy. Eur Heart J. 2017.
10. Baban A, Cicenia M, Maglio V, et al. Cardiovascular involvement in pediatric laminopathies. 2020. PMID:32793522.
11. Characterization of cardiac involvement in children with LMNA-related muscular dystrophy. 2023. PMID:36968203.
12. Liu S, Mo H, Chen X, et al. TNNT2 Mutation Affects the Progression of Dilated Cardiomyopathy in Children. JACC Asia. 2026. doi: 10.1016/j.jacasi.2026. 05.038.
13. Biallelic truncating variants in children with titinopathy represent a recognizable condition with distinctive muscular and cardiac characteristics. 2023. PMID:37576110.
14. American College of Medical Genetics and Genomics. Points to Consider for the Reporting of Variants of Uncertain Significance in Germline Genetic and Genomic Testing. 2026.
15. Predicting outcome in children with dilated cardiomyopathy: the use of repeated measurements of risk factors for outcome. ESC Heart Fail. 2021. PMID:33547769.
16. McNally EM, Mestroni L. Dilated cardiomyopathy: genetic determinants and mechanisms. Circ Res. 2017;121:731–748.
17. McNally EM, Golbus JR, Puckelwartz MJ. Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest. 2013;123:19–26.
18. Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013; 10:531–547.
19. ESC. Focus on Cardiomyopathies: genetic testing, counselling and risk stratification. 2023.
20. Outcome Predictors for Pediatric Dilated Cardiomyopathy: A Systematic Review. 2009. PMID: 19701490.
21. Dilated cardiomyopathy caused by truncating titin variants: long-term outcomes, arrhythmias, response to treatment and sex differences. J Med Genet. 2021. PMID:33106378.
22. Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the TTN Gene. 2020. PMID:32964742.
